Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|September 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responsesMinying Zhang, Jens Fritsche, Jason Roszik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular CarcinomaMarkus W Löffler, Stefania Gori, Francesco Izzo, et al.
Nature Medicine|July 31, 2012
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survivalSteffen Walter, Toni Weinschenk, Arnulf Stenzl, et al.
Science Translational Medicine|August 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapyGloria B Kim, Jens Fritsche, Sebastian Bunk, et al.
Nature Medicine|April 9, 2025
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trialMartin Wermke, Dejka M Araujo, Manik Chatterjee, et al.
Cancer Immunology Research|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic CancerApostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson, et al.
Nature|December 21, 2018
Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Nature|February 9, 2019
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastomaNorbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, et al.
Pageof 4